Francis L. Coolidge’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Francis L. Coolidge’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$38K	Buy	+657	New	+$40.4K	0.05%	170

Other funds holding OREX

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Francis L. Coolidge's OREX Position: Q2 2013 in Review

Francis L. Coolidge opened a new position in Orexigen Therapeutics, Inc. (OREX) in Q2 2013: 657 shares worth $38K. The stake represents 0.05% of the portfolio and ranks #170 among its holdings.

123 funds tracked by Wall St. Rank hold OREX as of Q2 2013.

Francis L. Coolidge held 657 shares of Orexigen Therapeutics, Inc. worth $38K as of Q2 2013.
Orexigen Therapeutics, Inc. was a new Francis L. Coolidge position in Q2 2013.
Orexigen Therapeutics, Inc. made up 0.05% of Francis L. Coolidge's portfolio in Q2 2013, its #170 holding.
123 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2013.

Based on Francis L. Coolidge's 13F filing for Q2 2013, filed 7 Aug 2013.